Fenwick Alan
Schistosomiasis Control Initiative, Imperial College, Department of Infectious Disease Epidemiology, St Mary's Campus, Norfolk Place, London W2 1PG, UK.
Trans R Soc Trop Med Hyg. 2006 Mar;100(3):200-7. doi: 10.1016/j.trstmh.2005.03.014. Epub 2005 Dec 15.
Since 1999, the funding available for the control of diseases of poverty (neglected diseases) has increased mainly due to leverage resulting from donations by the Bill and Melinda Gates Foundation and loans from the World Bank. Many countries have embarked on control programmes on a national scale due to drug donations by pharmaceutical companies through vertical programmes. The Schistosomiasis Control Initiative has expanded its operations to cover six countries in sub-Saharan Africa, but overlap of treatments between different vertical programmes is now a reality, and so care is needed to ensure that too many different drugs are not given together. Dialogue between programme managers has increased, and integration of some programmes may offer chances of synergy.
自1999年以来,用于控制贫困相关疾病(被忽视疾病)的可用资金有所增加,这主要得益于比尔及梅琳达·盖茨基金会捐赠所产生的杠杆效应以及世界银行的贷款。由于制药公司通过垂直项目进行药品捐赠,许多国家已在全国范围内启动了控制项目。血吸虫病控制倡议已将其业务扩展至撒哈拉以南非洲的六个国家,但不同垂直项目之间的治疗重叠如今已成为现实,因此需要谨慎确保不会同时使用过多不同的药物。项目管理人员之间的对话有所增加,部分项目的整合可能带来协同增效的机会。